SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,570.35 -373.93
( -0.49%)

Global Indices

Nasdaq

52,794.59 -412.31
(-0.77%)

Dow Jones

7,653.60 -53.54
(-0.69%)

Hang Seng

64,415.54 -1,799.80
(-2.72%)

Nikkei 225

10,761.93 -27.35
(-0.25%)

Forex

USD-INR

95.24 -0.24
(-0.25%)

EUR-INR

110.49 -0.08
(-0.07%)

GBP-INR

128.99 -0.20
(-0.15%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

17.05

15211.8

EPS(TTM)

Face Value()

Div & Yield %

49.8

0.59

Back

Shristi Infrastructure Development Corporation reports consolidated net loss of Rs 14.61 crore in the June 2026 quarter

Aug 13,2026

Net Loss of Shristi Infrastructure Development Corporation reported to Rs 14.61 crore in the quarter ended June 2026 as against net loss of Rs 4.62 crore during the previous quarter ended June 2025. Sales declined 62.27% to Rs 7.83 crore in the quarter ended June 2026 as against Rs 20.75 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	7.83	20.75	-62
OPM %	-122.22	7.28	-
PBDT	-13.21	-2.64	-400
PBT	-13.22	-2.66	-397
NP	-14.61	-4.62	-216

76,570.35 -373.93 ( -0.49%)

52,794.59 -412.31 (-0.77%)

7,653.60 -53.54 (-0.69%)

64,415.54 -1,799.80 (-2.72%)

10,761.93 -27.35 (-0.25%)

95.24 -0.24 (-0.25%)

110.49 -0.08 (-0.07%)

128.99 -0.20 (-0.15%)

0.60 0.00 (-0.03%)